Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.
People seeking to spend data on a specific physician will be searching through more than 600,000 physicians and/or going through 1,100 teaching hospital records with the latest update CMS makes in its Open Payments Database. At qordata, we have employed our data engineering chops to make your life just that much easier. This is the […]
CMS open payments reporting solution, qordata’s foremost solution for pharmaceutical spend analytics, helps drug and device manufacturers gain visibility into their spend data. With the publication of 2016 records by CMS on 30th June 2017, qordata has been amongst the first to share the industry’s most incisive insights in this blog. Data from 2016’s records […]
In our previous post on Dr. Klaus Geltsetzer’s webinar presentation, How to “Determine the Relationships of Different Global Disclosure Requirements,” we described how Germany’s consent rates tell an interesting story, depending on how they’re calculated. We’re resuming the debate on Germany’s position in the pharmaceutical transparency space. This time, we discuss industry-led, private-sector synergy. Or […]
The synergy between pharma associations may never materialize. It may even backfire. We will elaborate on this in an upcoming post, with the real-life case of pharma disclosure in Germany. Today, we discuss how public interest has surfaced as a surprisingly powerful ally in the pharma transparency movement. Before exploring the ‘whats’ and ‘hows’, we […]
In one of our most effective webinars this year, Wendy Derosa and Bryan Timer, both Compliance professionals at Merck USA, had useful advice for small and mid-sized pharmaceutical companies just starting out in the analytics space. Here’s what they had to say. 1. Start Small Before the emigration to a sophisticated analytics platform, it helps […]
Accidental discovery. Life changing consequence. Happens all the time, doesn’t it? Penicillin wouldn’t have been discovered if Alexander Fleming hadn’t observed unusual growth in his lab equipment. For others in the life sciences industry—particularly in compliance—discoveries don’t always have happy endings. Data discoveries are best made quickly and internally. Yet, that doesn’t seem to happen […]
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 2024. All rights reserved | Sitemap | Privacy Policy | Terms of Use